Published in Front Public Health on December 17, 2015
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Youth risk behavior surveillance--United States, 2013. MMWR Surveill Summ (2014) 6.17
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Herd immunity: history, theory, practice. Epidemiol Rev (1993) 5.44
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer (2007) 4.20
Current cigarette smoking among adults--United States, 2005-2013. MMWR Morb Mortal Wkly Rep (2014) 3.76
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014. MMWR Morb Mortal Wkly Rep (2015) 3.48
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. MMWR Morb Mortal Wkly Rep (2014) 3.41
Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis (2011) 3.16
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012. MMWR Morb Mortal Wkly Rep (2013) 2.67
National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013. MMWR Morb Mortal Wkly Rep (2014) 2.39
Polio eradication. Efficacy of inactivated poliovirus vaccine in India. Science (2014) 2.00
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis (2014) 1.92
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst (2002) 1.83
Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med (2011) 1.77
A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J (2013) 1.65
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40
Imperfect vaccines and herd immunity to HIV. Proc Biol Sci (1993) 1.36
Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics (2014) 1.31
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev (2005) 1.24
Meeting the Healthy People 2020 Objectives to Reduce Cancer Mortality. Prev Chronic Dis (2015) 1.16
Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol (2013) 1.11
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics (2012) 1.10
HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine (2014) 1.06
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother (2012) 1.00
Racial disparities in human papillomavirus vaccination: does access matter? J Adolesc Health (2013) 0.98
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc (2006) 0.98
Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus. J Clin Med (2015) 0.98
Factors affecting human papillomavirus vaccine use among White, Black and Latino parents of sons. Pediatr Infect Dis J (2013) 0.97
Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol (2011) 0.95
Experiences with polio vaccination and herd immunity in Finland. Dev Biol Stand (1981) 0.95
Immunogenicity and Safety of a 9-Valent HPV Vaccine. Pediatrics (2015) 0.94
Safety of human papillomavirus vaccines: a review. Expert Opin Drug Saf (2015) 0.92
The clinical efficacy of trivalent oral polio vaccine in The Gambia by season of vaccine administration. J Infect Dis (1997) 0.92
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon. Expert Rev Vaccines (2014) 0.91
Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions. J Womens Health (Larchmt) (2013) 0.91
HPV Carcinomas in Immunocompromised Patients. J Clin Med (2015) 0.90
Second-generation prophylactic HPV vaccines: successes and challenges. Expert Rev Vaccines (2013) 0.88
The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine (2012) 0.88
The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis (2014) 0.84
Evaluation of HPV infection and smoking status impacts on cell proliferation in epithelial layers of cervical neoplasia. PLoS One (2014) 0.84
Assessment of herd immunity from human papillomavirus vaccination. Lancet Infect Dis (2011) 0.83
Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine. Am J Epidemiol (1992) 0.83
Rural Healthy People 2020: New Decade, Same Challenges. J Rural Health (2015) 0.82
Epidemiological evaluation of oral polio vaccine efficacy in Delhi. Indian J Pediatr (1992) 0.81
Field trial on the efficacy of oral Sabin vaccine versus Salk polio vaccine. Dev Biol Stand (1981) 0.81
The role of parental attitudes and provider discussions in uptake of adolescent vaccines. Vaccine (2014) 0.81
Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection. Vaccine (2013) 0.81
The efficacy of polio vaccination in Finland. Dev Biol Stand (1978) 0.80
Salk and Sabin: poliomyelitis immunisation. J Neurol Neurosurg Psychiatry (2004) 0.79
The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection. Ther Adv Vaccines (2013) 0.77
Human papillomavirus vaccination uptake and completion as a preventive health measure among female adolescents. Nurs Outlook (2014) 0.77
HPV vaccines: their pathology-based discovery, benefits, and adverse effects. Ann Diagn Pathol (2015) 0.77
First generation prophylactic HPV vaccines: the state of the art. Minerva Med (2015) 0.76
Herd immunity results in reduced HPV infections in nonvaccinated teenagers. Expert Rev Vaccines (2012) 0.76
From culture to vaccine--Salk and Sabin. N Engl J Med (2004) 0.76
Field evaluation of trivalent oral polio vaccine efficacy in Madras city--a case control study. J Commun Dis (1994) 0.76
Epidemiological evaluation of oral polio vaccine efficacy in Cairo. J Egypt Public Health Assoc (1993) 0.76
Efficacy of three doses of oral polio immunization beginning within the first four days of life. Indian Pediatr (1990) 0.76
Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda. Health Care Women Int (2014) 0.76